Premium
Differential cytokine expressions affect the severity of peri‐implant disease
Clinical Oral Implants ResearchPeer ReviewedDuarte Poliana Mendes +52009Journals
Objective: This study assessed gene expression by quantitative polymerase chain reaction of inflammatory‐ [interleukin (IL)‐12, tumor necrosis factor‐α (TNF‐α), IL‐4, and IL‐10] and osteoclastogenesis‐related factors [receptor activator of NF‐κB ligand (RANKL) and osteoprotegerin (OPG)] in sites exhibiting different severities of peri‐implant disease. Material and methods: Peri‐implant soft tissue biopsies ( n =48) were harvested from healthy implant (HI), mucositis (MC), initial peri‐implantitis (IP) and severe peri‐implantitis (SP) sites. Results: IL‐12 and TNF‐α mRNA levels were higher in SP, followed by IP and MC ( P <0.05). IL‐4 was higher in HI, followed by MC, SP and IP ( P <0.05). IL‐10 was the lowest in HI, while no differences were detected among the diseased groups ( P >0.05). OPG mRNA levels were higher in HI, followed by IP, SP and MC, whereas RANKL was increased as the peri‐implantitis severity increased ( P <0.05). The highest OPG/RANKL ratio was observed in HI and the lowest in SP ( P <0.01). Conclusion: These findings suggest that expressions of inflammatory‐ and osteoclastogenesis‐related factors may play an important role in the onset and severity of the peri‐implant diseases.
This content is not available in your region!
Continue researching from Zendy home
Having issues? Contact support